Science Explorer Interactive view Map
Research facility · Madrid · Spain

Centro de Investigación Biomédica en Red de Cáncer

In research, Centro de Investigación Biomédica en Red de Cáncer stands highest in Medicine (#1,708 of 10,443 worldwide), Life Sciences (#1,318 of 7,800 worldwide) and Health Sciences (#2,345 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hematology, Oncology and Cancer Research — Hematology is 21.2× its share of world research.

ciberonc.esROR OpenAlex
World rank, 2022–2025
#3,099
of 28,054 · #5,780 all time
Rank in Spain
#66
of 658
Research works
950
▲ 827% vs 2013–17
Citations
30k
31.2 per fractional work
Top-10% rate
30.2%
record average 16.5%
Open access
72%
world 28%

What is Centro de Investigación Biomédica en Red de Cáncer known for in research?

The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorksAll time
MedicineField #1,708 of 10,443 31.4%229 #2866
Life SciencesDomain #1,318 of 7,800 28.9%150 #2539
Health SciencesDomain #2,345 of 11,982 31.4%232 #3839
OncologySubfield #289 of 772 34.7%67 #589
Biochemistry, Genetics and Molecular BiologyField #1,729 of 3,579 28.3%114 #3350
Molecular BiologySubfield #1,149 of 2,175 27.8%71 #2184

Each strip is that field’s whole ranked pool, with the notch where Centro de Investigación Biomédica en Red de Cáncer sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Which of those standings moved

The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.

  1. Medicine#2,866 #1,708
  2. Life Sciences#2,539 #1,318
  3. Health Sciences#3,839 #2,345
  4. Oncology#589 #289
  5. Biochemistry, Genetics and Molecular Biology#3,350 #1,729
  6. Molecular Biology#2,184 #1,149
all time2022–2025, better2022–2025, worse

A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.

What does Centro de Investigación Biomédica en Red de Cáncer specialise in?

Where its research is concentrated relative to its size: Hematology takes 21.2× the share of its output that it takes of world research.

  1. HematologySubfield · 25.8 works21×
  2. OncologySubfield · 67.2 works15×
  3. Cancer ResearchSubfield · 23.9 works14×
  4. ImmunologySubfield · 28.5 works10×
  5. Immunology and MicrobiologyField · 29.4 works7.3×
  6. Molecular BiologySubfield · 70.9 works5.8×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.31× its world share, 114 worksBiochemistry, Geneti…Immunology and Microbiology: 7.26× its world share, 29 worksImmunology and Micro…Neuroscience: 0.72× its world share, 5 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.74× its world share, 1 worksPharmacology, Toxico…Chemical Engineering: 0.03× its world share, 0 worksChemical EngineeringChemistry: 0.55× its world share, 4 worksChemistryComputer Science: 0.06× its world share, 2 worksComputer ScienceEnergy: 0.03× its world share, 0 worksEnergyEngineering: 0.12× its world share, 7 worksEngineeringEnvironmental Science: 0.05× its world share, 1 worksEnvironmental ScienceMaterials Science: 0.22× its world share, 3 worksMaterials ScienceMathematics: 0.09× its world share, 0 worksMathematicsPhysics and Astronomy: 0.06× its world share, 1 worksPhysics and AstronomyDentistry: 0.41× its world share, 1 worksDentistryHealth Professions: 0.12× its world share, 1 worksHealth ProfessionsMedicine: 2.97× its world share, 230 worksMedicineNursing: 0.23× its world share, 0 worksNursingVeterinary: 0.38× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 0.01× its world share, 0 worksBusiness, Management…Decision Sciences: 0.15× its world share, 1 worksDecision SciencesEconomics, Econometrics and Finance: 0.07× its world share, 1 worksEconomics, Econometr…Psychology: 0.05× its world share, 1 worksPsychologySocial Sciences: 0.01× its world share, 1 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.3×. Every wedge is a field page.

Which keywords describe research at Centro de Investigación Biomédica en Red de Cáncer?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Immunotherapy, Prognostic Factors, Chemotherapy, Tumor Microenvironment, Targeted Therapy, Lymphoma and Cancer Immunotherapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer36▲ 6.7×44 topics
  2. Immunotherapy32▲ 11×19 topics
  3. Prognostic Factors30▲ 17×14 topics
  4. Chemotherapy30▲ 11×23 topics
  5. Tumor Microenvironment26▲ 15×8 topics
  6. Targeted Therapy22▲ 25×5 topics
  7. Inflammation22▲ 2.6×65 topics
  8. Lymphoma22▲ 33×4 topics
  9. Cancer Immunotherapy20▲ 32×3 topics
  10. Cancer Therapy17▲ 7.2×18 topics
  11. Gene Expression16▲ 6.6×15 topics
  12. Rituximab16▲ 27×3 topics
  13. Clinical Trials15▲ 5.6×16 topics
  14. Immunity15▲ 9.2×10 topics
  15. Tumor Regression14▲ 31×2 topics
  16. PET Imaging14▲ 20×4 topics
  17. Biomarkers13▲ 4.8×15 topics
  18. Minimal Residual Disease13▲ 48×2 topics
  19. Proteasome Inhibitors13▲ 46×2 topics
  20. Genomic Instability13▲ 29×3 topics
  21. Leukemia13▲ 37×2 topics
  22. Metastasis13▲ 9.3×12 topics
  23. Staging System12▲ 51×2 topics
  24. Clinical Practice Guidelines12▲ 5.6×13 topics
  25. Immune Checkpoint Blockade12▲ 27×1 topic
  26. PD-1 and PD-L112▲ 27×1 topic
  27. CAR T Cells12▲ 41×1 topic
  28. Cell-Free DNA12▲ 30×2 topics
  29. Chimeric Antigen Receptor12▲ 41×1 topic
  30. Somatic Mutations12▲ 36×2 topics
  31. Cancer Genomics12▲ 41×1 topic
  32. Mutational Signatures12▲ 41×1 topic
  33. Hematopoietic Stem Cells12▲ 33×3 topics
  34. Diagnosis Criteria11▲ 79×1 topic
  35. International Myeloma Working Group11▲ 79×1 topic
  36. Breast Cancer11▲ 12×11 topics
  37. Innate Immunity11▲ 8.4×10 topics
  38. Transcriptional Regulation11▲ 17×9 topics
  39. Molecular Profiling10▲ 26×3 topics
  40. Neoadjuvant Therapy10▲ 11×5 topics

Which research topics does Centro de Investigación Biomédica en Red de Cáncer publish most on?

By volume in 2022–2025: Cancer Immunotherapy and Biomarkers, CAR-T cell therapy research, Cancer Genomics and Diagnostics and Multiple Myeloma Research and Treatments.

Cancer Immunotherapy and…12Cancer Immunotherapy and Biomarkers: 12 fractional worksCAR-T cell therapy resea…12CAR-T cell therapy research: 12 fractional worksCancer Genomics and Diag…12Cancer Genomics and Diagnostics: 12 fractional worksMultiple Myeloma Researc…11Multiple Myeloma Research and Treatments: 11 fractional worksLymphoma Diagnosis and Treatment: 9 fractional worksAcute Myeloid Leukemia Research: 8 fractional worksChronic Lymphocytic Leuk…7Chronic Lymphocytic Leukemia Research: 7 fractional worksImmunotherapy and Immune…7Immunotherapy and Immune Responses: 7 fractional worksCancer Cells and Metasta…7Cancer Cells and Metastasis: 7 fractional worksImmune Cell Function and…6Immune Cell Function and Interaction: 6 fractional works
OncologyCancer ResearchHematologyPathology and Forensic Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Immunotherapy and Biomarkers Oncology 12 works
  2. 2 CAR-T cell therapy research Oncology 12 works
  3. 3 Cancer Genomics and Diagnostics Cancer Research 12 works
  4. 4 Multiple Myeloma Research and Treatments Hematology 11 works
  5. 5 Lymphoma Diagnosis and Treatment Pathology and Forensic Medicine 9 works
  6. 6 Acute Myeloid Leukemia Research Hematology 8 works
  7. 7 Chronic Lymphocytic Leukemia Research Genetics 7 works
  8. 8 Immunotherapy and Immune Responses Immunology 7 works
  9. 9 Cancer Cells and Metastasis Oncology 7 works
  10. 10 Immune Cell Function and Interaction Immunology 6 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available71.7%not open28.3%

World: 28% of research is openly available.

with international co-authors41.5%domestic only58.5%

World: 19% is written across borders.

How has Centro de Investigación Biomédica en Red de Cáncer's research output changed?

Output in 2018–2022 was 827% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Madrid

All research institutions in Madrid

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.